Danaher EBITDA 2010-2024 | DHR
Danaher annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Danaher EBITDA for the quarter ending September 30, 2024 was $1.549B, a 9.84% decline year-over-year.
- Danaher EBITDA for the twelve months ending September 30, 2024 was $7.123B, a 0.44% increase year-over-year.
- Danaher 2023 annual EBITDA was $7.376B, a 23.71% decline from 2022.
- Danaher 2022 annual EBITDA was $9.668B, a 13.77% increase from 2021.
- Danaher 2021 annual EBITDA was $8.498B, a 31.49% increase from 2020.
Danaher Annual EBITDA
(Millions of US $) |
| 2023 |
$7,376 |
| 2022 |
$9,668 |
| 2021 |
$8,498 |
| 2020 |
$6,463 |
| 2019 |
$4,458 |
| 2018 |
$4,233 |
| 2017 |
$3,689 |
| 2016 |
$3,863 |
| 2015 |
$3,043 |
| 2014 |
$2,763 |
| 2013 |
$3,971 |
| 2012 |
$4,005 |
| 2011 |
$3,252 |
| 2010 |
$2,438 |
| 2009 |
$1,771 |
Danaher Quarterly EBITDA
(Millions of US $) |
| 2024-09-30 |
$1,549 |
| 2024-06-30 |
$1,748 |
| 2024-03-31 |
$1,923 |
| 2023-12-31 |
$1,903 |
| 2023-09-30 |
$1,718 |
| 2023-06-30 |
$1,703 |
| 2023-03-31 |
$2,052 |
| 2022-12-31 |
$1,619 |
| 2022-09-30 |
$2,555 |
| 2022-06-30 |
$2,757 |
| 2022-03-31 |
$2,737 |
| 2021-12-31 |
$1,560 |
| 2021-09-30 |
$1,880 |
| 2021-06-30 |
$2,530 |
| 2021-03-31 |
$2,528 |
| 2020-12-31 |
$2,149 |
| 2020-09-30 |
$1,800 |
| 2020-06-30 |
$1,519 |
| 2020-03-31 |
$995 |
| 2019-12-31 |
$1,261 |
| 2019-09-30 |
$1,072 |
| 2019-06-30 |
$1,110 |
| 2019-03-31 |
$1,016 |
| 2018-12-31 |
$815 |
| 2018-09-30 |
$1,152 |
| 2018-06-30 |
$1,202 |
| 2018-03-31 |
$1,064 |
| 2017-12-31 |
$716 |
| 2017-09-30 |
$1,071 |
| 2017-06-30 |
$980 |
| 2017-03-31 |
$923 |
| 2016-12-31 |
$1,019 |
| 2016-09-30 |
$976 |
| 2016-06-30 |
$988 |
| 2016-03-31 |
$881 |
| 2015-12-31 |
$265 |
| 2015-09-30 |
$616 |
| 2015-06-30 |
$1,171 |
| 2015-03-31 |
$991 |
| 2014-12-31 |
$941 |
| 2014-09-30 |
$1,071 |
| 2014-06-30 |
$1,125 |
| 2014-03-31 |
$1,014 |
| 2013-12-31 |
$1,077 |
| 2013-09-30 |
$1,038 |
| 2013-06-30 |
$1,063 |
| 2013-03-31 |
$948 |
| 2012-12-31 |
$1,083 |
| 2012-09-30 |
$966 |
| 2012-06-30 |
$1,019 |
| 2012-03-31 |
$937 |
| 2011-12-31 |
$983 |
| 2011-09-30 |
$851 |
| 2011-06-30 |
$729 |
| 2011-03-31 |
$689 |
| 2010-12-31 |
$659 |
| 2010-09-30 |
$649 |
| 2010-06-30 |
$615 |
| 2010-03-31 |
$515 |
| 2009-12-31 |
$370 |
| 2009-09-30 |
$550 |
| 2009-06-30 |
$430 |
| 2009-03-31 |
$421 |
| Sector |
Industry |
Market Cap |
Revenue |
| Multi-Sector Conglomerates |
Diversified Operations |
$163.350B |
$23.890B |
|
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
|
